Good day, and welcome to the Fourth Quarter 2024 Harvard Bioscience Earnings Conference Call. At this time, all participants are in listen-only mode. After the speakers' presentation, there will be a ...

2015 saw many advances in 3-D printing in the world of medicine, with rigid medical devices such as hearing aids, dental implants and ... BMS and AbbVie's Empliciti (elotuzumab) was the last ...

AbbVie Inc. (NYSE:ABBV) entered the obesity race last week when it in-licensed GUB014295 (also called GUBamy) from Denmark-based Gubra. The candidate is a long-acting amylin analog for the ...

Today's Research Daily features new research reports on 12 major stocks, including AbbVie Inc. (ABBV), Lockheed Martin Corp. (LMT) and Dell Technologies Inc. (DELL), as well as a micro-cap stock ...

AbbVie has secured its fourth FDA approval for Vraylar, adding adjunctive therapy of major depressive disorder (MDD) to a list that includes schizophrenia and manic and depressive episodes in ...

a man survived for over 100 days with his BiVACOR implant, and was even temporarily discharged from the medical facility with it still pumping blood inside him. The titanium device’s underlying ...

We sell different types of products and services to both investment professionals and individual investors. These products and services are usually sold through license agreements or subscriptions ...

Pre-Market: 7:14:19 a.m. EDT Loading Chart for ABBV ...

The company stated in a press release 2 that Hashad previously served as senior vice president and head of R&D for Allergan Aesthetics (Abbvie Company), in which he oversaw the development of more ...